Blood Test for Lung Cancer May be Possible

	Tweet

A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society’s 2008 International Conference in Toronto on Tuesday, May 20.

The possibility of developing a non-invasive test to distinguish cancerous from benign lesions in the lungs has enormous implications, not just for the world of medicine, but for every individual patient who has gone through the harrowing experience of having to wait for conclusive biopsy results after preliminary testing.

“CT screening results in the detection of lung nodules in 20 to 60 percent of subjects,” said Anil Vachani, M.D., assistant professor of medicine at the University of Pennsylvania. “This high false-positive rate requires patients to undergo extensive follow-up investigations, such as serial CT scans, PET scans or biopsies. This test may be able to obviate the need for such things if it is developed into a large scale diagnostic tool.”

Because lung cancer is a very diverse disease, screening for it can be very difficult. The researchers hoped to identify a stable and consistent way of determining the presence of lung cancer by testing for the gene expression of white blood cells.

Rather than screening for factors released by the incipient tumor into the blood stream, the test Dr. Vachani and colleagues used looked at gene expression in the subject’s own circulating white blood cells. “We found that the types of genes present in these cells could tell us whether or not cancer was present,” explained Dr. Vachani.

To test the accuracy and validity of the method, the researchers recruited 44 patients with early stage lung cancer and 52 control subjects who were matched for age, smoking status, gender and race. They then used a number of genetic arrays to determine the best targets for detecting the presence of cancer. They found that a 15 gene array had the highest accuracy, at 87 percent.

“These findings suggest that lung cancers interact with circulating white blood cells and change the types of genes that are active in these cells. This finding can be potentially used to develop a non-invasive diagnostic test for patients suspected of having lung cancer,” said Dr. Vachani. “A diagnostic test that could more accurately determine the risk of cancer in patients would be extremely valuable and have very important economic implications by reducing unnecessary surgery, biopsies and repeated imaging tests.”

“We are planning to perform validation studies to further evaluate the utility of this approach for diagnosing lung cancer in a larger population, concluded Dr Vachani. “If our results are encouraging, we would like to test this in a prospective clinical trial.”

Press Conference: Monday, May 19, 11:15 a.m., Room 101, North Building, Metro Toronto Convention Centre

Source: American Thoracic Society (ATS)

RELATED STORIES:
Many lung cancer patients get radiation therapy that may not prolong their lives   Long-Term Use of Nutrient Supplements May Increase Cancer Risk   Lung cancer tied to family risk of other cancers   Chest x-rays detect early lung cancer   Gene combination increases risk of lung cancer, particularly in light smokers, CAMH study finds   Gene variations directly link inflammation to an increased risk for lung cancer   Study Shows Minimally Invasive Lung Surgery Has Low Risk   New lung cancer staging system revealed   Study shows way to predict lung cancer recurrence   Tobacco smoke causes lung inflammation, promotes lung cancer growth   Tumor budding identified as predictor for unfavorable outcome in lung cancer   Age no bar to benefits of lung cancer chemo   US doctors resume test of drug to fight lung cancer   Non-Surgical Treatment Gives Lung Cancer Patients Three Years or More   New lung cancer research finds half of advanced lung cancer patients receive chemotherapy   PET imaging may improve lung cancer diagnosis   Micro-RNA determines malignancy of lung cancer   New research confirms need for lung cancer testing   Asian lung cancer patient survival exceeds Caucasians’ on multiple regimens   Gold nanotech breath test may show lung cancer early   Tooth Loss Linked to Esophageal, Head and Neck, and Lung Cancer   China has become the 89th country to ratify the global tobacco treaty

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]